Paul Jansson

411 total citations
8 papers, 284 citations indexed

About

Paul Jansson is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Paul Jansson has authored 8 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Physiology and 2 papers in Psychiatry and Mental health. Recurrent topics in Paul Jansson's work include Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Asthma and respiratory diseases (2 papers) and Respiratory Support and Mechanisms (2 papers). Paul Jansson is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Asthma and respiratory diseases (2 papers) and Respiratory Support and Mechanisms (2 papers). Paul Jansson collaborates with scholars based in Sweden, United Kingdom and Netherlands. Paul Jansson's co-authors include Ralph Brattsand, Anna Miller‐Larsson, Anna Runström, F.‐A. Wiesel, A. Wahlén, Göran Sedvall, Lars Farde, Bartolomé R. Celli, Raolat M. Abdulai and Naimish Patel and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Medicinal Chemistry and Psychopharmacology.

In The Last Decade

Paul Jansson

7 papers receiving 275 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Jansson Sweden 6 128 103 60 54 51 8 284
H.M. Jennewein Germany 12 61 0.5× 101 1.0× 96 1.6× 16 0.3× 87 1.7× 16 425
N Maltby United Kingdom 7 66 0.5× 139 1.3× 31 0.5× 34 0.6× 45 0.9× 9 328
Thomas K. Shaughnessy United States 7 38 0.3× 79 0.8× 29 0.5× 15 0.3× 72 1.4× 12 205
Akiyoshi Ohtake Japan 15 66 0.5× 60 0.6× 42 0.7× 37 0.7× 87 1.7× 39 646
Raf Magar United States 9 37 0.3× 66 0.6× 70 1.2× 63 1.2× 109 2.1× 21 457
Guillaume Birraux France 5 41 0.3× 86 0.8× 95 1.6× 19 0.4× 183 3.6× 6 310
Bin Ma China 10 71 0.6× 32 0.3× 7 0.1× 46 0.9× 74 1.5× 20 345
Aikaterini Anastasiou Greece 6 16 0.1× 113 1.1× 30 0.5× 36 0.7× 66 1.3× 17 268
Shiying Sheng China 10 37 0.3× 32 0.3× 46 0.8× 19 0.4× 84 1.6× 23 261
H. Schw�rer Germany 11 19 0.1× 88 0.9× 90 1.5× 15 0.3× 102 2.0× 14 372

Countries citing papers authored by Paul Jansson

Since Specialization
Citations

This map shows the geographic impact of Paul Jansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Jansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Jansson more than expected).

Fields of papers citing papers by Paul Jansson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Jansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Jansson. The network helps show where Paul Jansson may publish in the future.

Co-authorship network of co-authors of Paul Jansson

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Jansson. A scholar is included among the top collaborators of Paul Jansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Jansson. Paul Jansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Cooper, Martin, Antonio Llinàs, Asim K. Ray, et al.. (2020). Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists. Journal of Medicinal Chemistry. 63(17). 9705–9730. 17 indexed citations
2.
Higham, Andrew, et al.. (2018). Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells. International Journal of COPD. Volume 13. 1279–1288. 22 indexed citations
3.
Abdulai, Raolat M., Naimish Patel, Michael I. Polkey, et al.. (2017). Deterioration of Limb Muscle Function during Acute Exacerbation of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 197(4). 433–449. 68 indexed citations
4.
Steckelings, U. Muscha, Petri J. Vainío, Björn Dahlöf, et al.. (2017). [PP.02.17] SUCCESSFUL COMPLETION OF A PHASE I, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, SINGLE ASCENDING DOSE TRIAL FOR THE FIRST IN CLASS ANGIOTENSIN AT2-RECEPTOR AGONIST COMPOUND 21. Journal of Hypertension. 35(Supplement 2). e105–e106. 11 indexed citations
5.
Patel, Naimish, Danen Cunoosamy, Rikard Pehrson, et al.. (2015). AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans. OA483–OA483. 1 indexed citations
6.
Miller‐Larsson, Anna, Paul Jansson, Anna Runström, & Ralph Brattsand. (2000). Prolonged Airway Activity and Improved Selectivity of Budesonide Possibly Due to Esterification. American Journal of Respiratory and Critical Care Medicine. 162(4). 1455–1461. 69 indexed citations
7.
Widerlöv, E., et al.. (1990). Pharmacokinetics of remoxipride controlled release and immediate release capsules in schizophrenic patients.. PubMed. 5(2). 125–34. 2 indexed citations
8.
Farde, Lars, et al.. (1988). An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET. Psychopharmacology. 94(1). 1–7. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H.M. Jennewein Breakdown of academic impact, for papers by N Maltby Breakdown of academic impact, for papers by Thomas K. Shaughnessy Breakdown of academic impact, for papers by Akiyoshi Ohtake Breakdown of academic impact, for papers by Raf Magar Breakdown of academic impact, for papers by Guillaume Birraux Breakdown of academic impact, for papers by Bin Ma Breakdown of academic impact, for papers by Aikaterini Anastasiou Breakdown of academic impact, for papers by Shiying Sheng Breakdown of academic impact, for papers by H. Schw�rer
Rankless by CCL
2026